|
1
|
Abdulhannan P, Russell DA and
Homer-Vanniasinkam S: Peripheral arterial disease: A literature
review. Br Med Bull. 104:21–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirsch AT, Halverson SL, Treat-Jacobson D,
Hotvedt PS, Lunzer MM, Krook S, Rajala S and Hunninghake DB: The
minnesota regional peripheral arterial disease screening program:
Toward a definition of community standards of care. Vasc Med.
6:87–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ramos R, Quesada M, Solanas P, Subirana I,
Sala J, Vila J, Masiá R, Cerezo C, Elosua R, Grau M, et al:
Prevalence of symptomatic and asymptomatic peripheral arterial
disease and the value of the ankle-brachial index to stratify
cardiovascular risk. Eur J Vasc Endovasc Surg. 38:305–311. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q
and Hughes JP: Prevalence of peripheral arterial disease and risk
factors in persons aged 60 and older: Data from the National Health
and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc.
55:583–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krishna SM, Moxon JV and Golledge J: A
review of the pathophysiology and potential biomarkers for
peripheral artery disease. Int J Mol Sci. 16:11294–11322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siti HN, Kamisah Y and Kamsiah J: The role
of oxidative stress, antioxidants and vascular inflammation in
cardiovascular disease (a review). Vascul Pharmacol. 71:40–56.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barbagallo I, Galvano F, Frigiola A,
Cappello F, Riccioni G, Murabito P, D'Orazio N, Torella M, Gazzolo
D and Li Volti G: Potential therapeutic effects of natural heme
oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox
Signal. 18:507–521. 2013. View Article : Google Scholar
|
|
8
|
Novo G, Cappello F, Rizzo M, Fazio G,
Zambuto S, Tortorici E, Marino Gammazza A, Corrao S, Zummo G, De
Macario EC, et al: Hsp60 and heme oxygenase-1 (Hsp32) in acute
myocardial infarction. Transl Res. 157:285–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barbagallo I, Nicolosi A, Calabrese G,
David S, Cimino S, Madonia M and Cappello F: The role of the heme
oxygenase system in the metabolic syndrome. Curr Pharm Des.
20:4970–4974. 2014. View Article : Google Scholar
|
|
10
|
Li Volti G, Sacerdoti D, Di Giacomo C,
Barcellona ML, Scacco A, Murabito P, Biondi A, Basile F, Gazzolo D,
Abella R, et al: Natural heme oxygenase-1 inducers in hepatobiliary
function. World J Gastroenterol. 14:6122–6132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Volti G, Sorrenti V, Murabito P,
Galvano F, Veroux M, Gullo A, Acquaviva R, Stacchiotti A, Bonomini
F, Vanella L and Di Giacomo C: Pharmacological induction of heme
oxygenase-1 inhibits iNOS and oxidative stress in renal
ischemia-reperfusion injury. Transplant Proc. 39:2986–2991. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Volti G, Seta F, Schwartzman ML,
Nasjletti A and Abraham NG: Heme oxygenase attenuates angiotensin
II-mediated increase in cyclooxygenase-2 activity in human femoral
endothelial cells. Hypertension. 41:715–719. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kushida T, LiVolti G, Goodman AI and
Abraham NG: TNF-alpha-mediated cell death is attenuated by
retrovirus delivery of human heme oxygenase-1 gene into human
microvessel endothelial cells. Transplant Proc. 34:2973–2978. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sacerdoti D, Colombrita C, Ghattas MH,
Ismaeil EF, Scapagnini G, Bolognesi M, Li Volti G and Abraham NG:
Heme oxygenase-1 transduction in endothelial cells causes
downregulation of monocyte chemoattractant protein-1 and of genes
involved in inflammation and growth. Cell Mol Biol
(Noisy-le-grand). 51:363–370. 2005.
|
|
15
|
Marrazzo G, Bosco P, La Delia F,
Scapagnini G, Di Giacomo C, Malaguarnera M, Galvano F, Nicolosi A
and Li Volti G: Neuroprotective effect of silibinin in diabetic
mice. Neurosci Lett. 504:252–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Volti G, Sacerdoti D, Sangras B,
Vanella A, Mezentsev A, Scapagnini G, Falck JR and Abraham NG:
Carbon monoxide signaling in promoting angiogenesis in human
microvessel endothelial cells. Antioxid Redox Signal. 7:704–710.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Volti G, Wang J, Traganos F, Kappas A
and Abraham NG: Differential effect of heme oxygenase-1 in
endothelial and smooth muscle cell cycle progression. Biochem
Biophys Res Commun. 296:1077–1082. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tibullo D, Barbagallo I, Giallongo C, La
Cava P, Parrinello N, Vanella L, Stagno F, Palumbo GA, Li Volti G
and Di Raimondo F: Nuclear translocation of heme oxygenase-1
confers resistance to Imatinib in chronic myeloid leukemia cells.
Curr Pharm Des. 19:2765–2770. 2013. View Article : Google Scholar
|
|
19
|
Rizzo M, Abate N, Chandalia M, Rizvi AA,
Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER,
Banach M, et al: Liraglutide reduces oxidative stress and restores
heme oxygenase-1 and ghrelin levels in patients with type 2
diabetes: A prospective pilot study. J Clin Endocrinol Metab.
100:603–606. 2015. View Article : Google Scholar :
|
|
20
|
Li Volti G, Galvano F, Frigiola A,
Guccione S, Di Giacomo C, Forte S, Tringali G, Caruso M, Adekoya OA
and Gazzolo D: Potential immunoregulatory role of heme oxygenase-1
in human milk: A combined biochemical and molecular modeling
approach. J Nutr Biochem. 21:865–871. 2010. View Article : Google Scholar
|
|
21
|
Fontaine R, Kim M and Kieny R: Surgical
treatment of peripheral circulation disorders. Helv Chir Acta.
21:499–533. 1954.In German. PubMed/NCBI
|
|
22
|
Malaguarnera M, Vacante M, Giordano M,
Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G and
Galvano F: Oral acetyl-L-carnitine therapy reduces fatigue in overt
hepatic encephalopathy: A randomized, double-blind,
placebo-controlled study. Am J Clin Nutr. 93:799–808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nibali L, Rizzo M, Li Volti G, D'Aiuto F,
Giglio RV, Barbagallo I, Pelekos G and Donos N: Lipid subclasses
profiles and oxidative stress in aggressive periodontitis before
and after treatment. J Periodontal Res. 50:890–896. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Volti G, Musumeci T, Pignatello R,
Murabito P, Barbagallo I, Carbone C, Gullo A and Puglisi G:
Antioxidant potential of different melatonin-loaded nanomedicines
in an experimental model of sepsis. Exp Biol Med (Maywood).
237:670–677. 2012. View Article : Google Scholar
|
|
25
|
Li Volti G, Salomone S, Sorrenti V,
Mangiameli A, Urso V, Siarkos I, Galvano F and Salamone F: Effect
of silibinin on endothelial dysfunction and ADMA levels in obese
diabetic mice. Cardiovasc Diabetol. 10:622011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rani V, Deep G, Singh RK and Palle K:
Pathogenesis and therapeutic strategies. Life Sci. 148:183–193.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niki E: Biomarkers of lipid peroxidation
in clinical material. Biochim Biophys Acta. 1840:809–817. 2014.
View Article : Google Scholar
|
|
28
|
Rossi P, Riutta A, Kuukasjärvi P, Vehmas
T, Mucha I and Salenius JP: Revascularization decreases
8-isoprostaglandin F2alpha excretion in chronic lower limb
ischemia. Prostaglandins Leukot Essent Fatty Acids. 71:97–101.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang Y, Wei P, Duke RW, Reaven PD, Harman
SM, Cutler RG and Heward CB: Quantification of
8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin
F(2alpha) in human urine using liquid chromatography-tandem mass
spectrometry. Free Radic Biol Med. 34:409–418. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ho DY, Cook NR, Britton KA, Kim E, Creager
MA, Ridker PM and Pradhan AD: High-molecular-weight and total
adiponectin levels and incident symptomatic peripheral artery
disease in women: A prospective investigation. Circulation.
124:2303–2311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato T, Saito Y, Inoue S, Shimosato T,
Takagi S, Kaneko T and Ishigatsubo Y: Serum heme oxygenase-1 as a
marker of lung function decline in patients with chronic silicosis.
J Occup Environ Med. 54:1461–1466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin Q, Weis S, Yang G, Weng YH, Helston R,
Rish K, Smith A, Bordner J, Polte T, Gaunitz F and Dennery PA: Heme
oxygenase-1 protein localizes to the nucleus and activates
transcription factors important in oxidative stress. J Biol Chem.
282:20621–20633. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abraham NG, Rezzani R, Rodella L, Kruger
A, Taller D, Li Volti G, Goodman AI and Kappas A: Overexpression of
human heme oxygenase-1 attenuates endothelial cell sloughing in
experimental diabetes. Am J Physiol Heart Circ Physiol.
287:H2468–H2477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jais A, Einwallner E, Sharif O, Gossens K,
Lu TT, Soyal SM, Medgyesi D, Neureiter D, Paier-Pourani J, Dalgaard
K, et al: Heme oxygenase-1 drives metaflammation and insulin
resistance in mouse and man. Cell. 158:25–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang JY, Chiang MT, Yet SF and Chau LY:
Myeloid heme oxygenase-1 haploinsufficiency reduces high fat
diet-induced insulin resistance by affecting adipose macrophage
infiltration in mice. PLoS One. 7:e386262012. View Article : Google Scholar : PubMed/NCBI
|
